HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30.
Diagnosis & Disease Information
American Cancer Society Updates HPV Vaccination Guidelines
Vaccination should be routinely offered at age 9 to 12 years; catch-up vaccination recommended through age 26.
Multilevel Interventions May Boost HPV Vaccination Rates
Improvements in initiation and completion extend beyond conclusion of the intervention.
Studies Confirm Safety of 9-Valent HPV Vaccination
Studies based on searching Vaccine Adverse Event Reporting System, six Vaccine Safety Datalink sites.
Men Less Knowledgeable About HPV, HPV Vaccination
Most men and women did not know anal, penile, and oral cancers are caused by HPV.
Room for Improvement Found in HPV Vaccine Delivery Practices
Physicians not strongly recommending vaccine, not using presumptive style linked to refusal or deferral.
One Dose of HPV Vaccine May Be Sufficient in Certain Situations
One dose compared with two or three doses in preventing cervical precancer in high-coverage settings.
Targeted Interventions Raise HPV Vaccine Acceptance in Women
Educational videos produced the highest rate of acceptability and knowledge.
Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates
Self-persuasion is more effective than external persuasion for motivating low-income parents to vaccinate their children against HPV.
HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women
Fewer cervical cell anomalies were present on cervical cancer screens of young women in Canada who received the HPV vaccine through a school-based program.
- Loading...
Loading...
Loading... 
Loading...